Latest papers

NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas.

Neuroendocrine tumors: a critical appraisal of management strategies.

Pancreatic endocrine tumors less than 4 cm in diameter: resect or enucleate? a single-center experience.

The North American Neuroendocrine Tumor Society (NANETS) guidelines: mission, goals, and process.

The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems.

The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectum.

NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the thorax (includes lung and thymus).

Compensatory activation of Akt in response to mTOR and Raf inhibitors - a rationale for dual-targeted therapy approaches in neuroendocrine tumor disease.

Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors.

Paracrine factors produced by bone marrow stromal cells induce apoptosis and neuroendocrine differentiation in prostate cancer cells.

Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors.

An insidious pancreatic lesion in a young woman with recurrent pancreatitis.

Development of a highly sensitive and specific carboxy-terminal human pancreastatin assay to monitor neuroendocrine tumor behavior.

Neuroendocrine pancreatic tumor and dermatomyositis.

[Curatively resected case of non-functioning pancreatic neuroendocrine carcinoma with multiple liver metastases after downstaging with S-1 monotherapy].

[Analysis on clinical characteristics of rectal neuroendocrine tumors].

Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy.

The 5-HT(2B) receptor plays a key regulatory role in both neuroendocrine tumor cell proliferation and the modulation of the fibroblast component of the neoplastic microenvironment.

EUS for pancreatic neuroendocrine tumors: a single-center, 11-year experience.

Thymic neuroendocrine tumors: a SEER database analysis of 160 patients.